Mark E. Gurney
Impact in
- Developmental Biology top 0.5%
- Animal Vocal Communication and Behavior
- Neurology top 0.5%
- Amyotrophic Lateral Sclerosis Research
- Parkinson's Disease Mechanisms and Treatments
Papers in
-
- Phosphodiesterase function and regulation 22
- Receptor Mechanisms and Signaling 12
- Pharmacology 21
- Cholinesterase and Neurodegenerative Diseases 14
- Inflammatory mediators and NSAID effects 6
- Co-authors
- Masakazu Konishi (2 shared papers)Edward D. Hall (4 shared papers)Paula K. Andrus (2 shared papers)Alex B. Burgin (6 shared papers)Timothy J. Fleck (2 shared papers)Ping Zhai (3 shared papers)Rong Xu (7 shared papers)Adele M. Pauley (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Annals of Neurology (4 papers)Alzheimer s & Dementia (3 papers)Journal of Medicinal Chemistry (3 papers)Scientific Reports (2 papers)
- Partner nations
- United StatesIcelandAustralia
In The Last Decade
Mark E. Gurney
69 papers receiving 5.3k citations
Mark E. Gurney's Hit Papers
Peers
Comparison fields: 5 of 134
- Developmental Biology 536
- Neurology 1.5k
- Genetics 785
- Neurology 479
- Pharmacology 891
Countries citing papers authored by Mark E. Gurney
This map shows the geographic impact of Mark E. Gurney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Gurney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Gurney more than expected).
Fields of papers citing papers by Mark E. Gurney
This network shows the impact of papers produced by Mark E. Gurney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Gurney. The network helps show where Mark E. Gurney may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Gurney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis Hit paper breakdown → | 1996 | 531 |
| 2 | 1980 | 345 | |
| 3 | 2009 | 331 | |
| 4 | 2001 | 324 | |
| 5 | 2001 | 281 | |
| 6 | 1998 | 229 | |
| 7 | 1997 | 205 | |
| 8 | COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US Hit paper breakdown → | 2021 | 169 |
| 9 | 1997 | 157 | |
| 10 | 1981 | 157 | |
| 11 | 1982 | 145 | |
| 12 | 1998 | 138 | |
| 13 | 2020 | 117 | |
| 14 | 1998 | 114 | |
| 15 | 2009 | 100 | |
| 16 | 2014 | 99 | |
| 17 | 2009 | 94 | |
| 18 | 1984 | 93 | |
| 19 | 2021 | 90 | |
| 20 | 1997 | 85 |
About Mark E. Gurney
Mark E. Gurney is a scholar working on Molecular Biology, Pharmacology, Neurology, Genetics and Physiology, having authored 70 papers that have together received 5.4k indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (22 papers), Cholinesterase and Neurodegenerative Diseases (14 papers), Amyotrophic Lateral Sclerosis Research (13 papers), Receptor Mechanisms and Signaling (12 papers), Neurogenetic and Muscular Disorders Research (8 papers), Inflammatory mediators and NSAID effects (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Neurological diseases and metabolism (5 papers). The work is most often cited by research in Developmental Biology (536 citations), Neurology (1.5k citations), Genetics (785 citations), Neurology (479 citations) and Pharmacology (891 citations). Mark E. Gurney has collaborated with scholars based in United States, Iceland and Australia. Frequent co-authors include Masakazu Konishi, Edward D. Hall, Paula K. Andrus, Alex B. Burgin, Timothy J. Fleck, Ping Zhai, Rong Xu, Adele M. Pauley, Jinhe Li and Lawrence C Katz. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Annals of Neurology, Alzheimer s & Dementia, Journal of Medicinal Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.